Stephen Hoge

Stephen leads strategy, business development, and preclinical oncology for Moderna and is the inventor of several mRNA patents. Prior to Moderna, Stephen was a partner at McKinsey & Company and a leader in the firm’s Healthcare and Corporate Finance practices. At McKinsey Stephen advised senior management teams of leading biotech and pharmaceutical companies on a wide range of strategic, financial and operational issues.

Prior to joining the firm, Stephen was a physician in New York.

He holds an M.D. with thesis from the University of California, San Francisco, and a B.S. in Neuroscience from Amherst College.

Stephen Hoge is the President at Moderna, based in United States, North America. With a background in Biotechnology, Stephen Hoge has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.